Since PBMC of MS patients cultured with TSA failed to show an increase in cellular expression of p53, we predicted that PBMC of MS patients will be less susceptible to TSA induced apoptosis when compared to healthy controls. This evidence concerns the gene TP53 and myeloid sarcoma.